SCHEMBL8230438

SCHEMBL8230438

Nc1ccc(N2CCN(C(=O)CN3CCCC3)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.73
ALDH1A1 P00352 4/20 0.73
GFER P55789 3/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
CASP6 P55212 1/20 0.58
GAA P10253 4/20 0.56
KMT2A Q03164 5/20 0.53
MEN1 O00255 4/20 0.53
TSHR P16473 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
NPSR1 Q6W5P4 2/20 0.51
PKM P14618 1/20 0.51
KDM4E B2RXH2 2/20 0.50
LMNA P02545 2/20 0.50
NPC1 O15118 1/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3440160 0.94 GFER (0.74) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL20354370 0.93 GFER (0.72) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL13832680 0.85 SMN1; SMN2 (0.89) MAPTALDH1A1GFERSMN1; SMN2GAA
SCHEMBL13832674 0.84 ALDH1A1 (0.71) MAPTALDH1A1GFERSMN1; SMN2GAA
SCHEMBL19294333 0.84 SMN1; SMN2 (0.86) MAPTALDH1A1GFERSMN1; SMN2GAA
SCHEMBL188832 0.81 AKR1C3 (0.65) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL15650594 0.81 GFER (0.65) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL1813106 0.80 GFER (0.68) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL4985735 0.79 AKR1C3 (0.68) MAPTALDH1A1GFERSMN1; SMN2CASP6
SCHEMBL17076742 0.79 MAPT (0.53) MAPTALDH1A1GFERSMN1; SMN2CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007089768-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EXELIXIS, INC. (US) 2007-08-09 WO disclosed